Effect of topical application of melatonin on serum levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-a) in patients with type 1 or type 2 diabetes and periodontal disease
Author(s) -
Antonio Cutando,
Javier Montero,
Rafael Gómez-de Diego,
MJ Ferrera,
Antonio LópezValverde
Publication year - 2015
Publication title -
journal of clinical and experimental dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.481
H-Index - 23
ISSN - 1989-5488
DOI - 10.4317/jced.52604
Subject(s) - medicine , melatonin , diabetes mellitus , tumor necrosis factor alpha , nephelometry , c reactive protein , placebo , endocrinology , type 2 diabetes , interleukin , gastroenterology , interleukin 6 , immunology , inflammation , cytokine , pathology , antibody , alternative medicine
The present clinical trial study was designed to assess the effect of topical application of melatonin on serum levels of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) in patients with diabetes and periodontal disease in comparison with healthy controls.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom